Literature DB >> 3950818

Kawasaki disease: review of risk factors for coronary aneurysms.

G Koren, S Lavi, V Rose, R Rowe.   

Abstract

Between June 1, 1979, and May 31, 1984, at The Hospital for Sick Children in Toronto, Kawasaki disease was diagnosed in 163 patients (112 boys, 51 girls, P less than 0.001). Fifteen percent of the children had coronary artery aneurysms. Prior to diagnosis, 24% had been given low doses of aspirin, and 50% acetaminophen. Children with coronary aneurysms had significantly higher temperature during days 10 to 13 of the disease. The febrile phase of the disease was also significantly longer in these children. Coronary artery involvement occurred with equal frequency in boys and girls. There was no significantly greater incidence of coronary artery involvement in infants younger than 1 year of age than in older children. Duration of fever (greater than or equal to 14 days vs less than 14 days) was equally as predictive of the eventual occurrence of coronary aneurysms as the modified Asai score.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950818     DOI: 10.1016/s0022-3476(86)80878-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  40 in total

1.  Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.

Authors:  M Miura; H Ohki; T Tsuchihashi; H Yamagishi; Y Katada; K Yamada; Y Yamashita; A Sugaya; O Komiyama; H Shiro
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

2.  Atypical Kawasaki disease: an often missed diagnosis.

Authors:  K Boven; E R De Graeff-Meeder; W Spliet; W Kuis
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

3.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

Review 4.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

5.  Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation.

Authors:  Mark Gorelik; David C Wilson; Yona K Cloonan; Stanford T Shulman; Raphael Hirsch
Journal:  J Pediatr       Date:  2012-02-07       Impact factor: 4.406

6.  Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease.

Authors:  Jae-Jung Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung Ki Han; Min Seob Song; Hyoung Doo Lee; Jung Hye Byeon; Saejung Sohn; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee
Journal:  Pediatr Cardiol       Date:  2014-09-30       Impact factor: 1.655

7.  Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease.

Authors:  Kothandam Sivakumar; Sreeja Pavithran
Journal:  Pediatr Cardiol       Date:  2012-03-18       Impact factor: 1.655

8.  Recognizing Kawasaki disease.

Authors:  B Lang
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 9.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

10.  Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Ja-Hyun Hong; Hyung-Shin Lee; Joon-Sung Lee; Kyung-Tai Whang
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.